Daiichi Sankyo (OTCMKTS:DSNKY) Hits New 52-Week Low – What’s Next?

Daiichi Sankyo Company, Limited (OTCMKTS:DSNKYGet Free Report) shares reached a new 52-week low on Wednesday . The company traded as low as $22.76 and last traded at $22.99, with a volume of 213654 shares. The stock had previously closed at $23.78.

Daiichi Sankyo Trading Down 3.3 %

The company has a fifty day moving average price of $27.08 and a 200-day moving average price of $31.97. The firm has a market capitalization of $43.87 billion and a price-to-earnings ratio of 26.73. The company has a current ratio of 2.77, a quick ratio of 2.11 and a debt-to-equity ratio of 0.06.

Daiichi Sankyo (OTCMKTS:DSNKYGet Free Report) last posted its earnings results on Friday, January 31st. The company reported $0.22 earnings per share (EPS) for the quarter. Daiichi Sankyo had a net margin of 13.62% and a return on equity of 14.53%. On average, equities research analysts predict that Daiichi Sankyo Company, Limited will post 0.73 EPS for the current year.

About Daiichi Sankyo

(Get Free Report)

Daiichi Sankyo Company, Limited manufactures, markets, and sells pharmaceutical products worldwide. The company offers Enhertu, a HER2 directed antibody drug conjugate; Turalio, a CSF-1R inhibitor; Vanflyta, a FLT3 inhibitor for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia; ferric carboxymaltose injection for treating anaemia; and Injectafer for the treatment for iron deficiency anaemia.

Read More

Receive News & Ratings for Daiichi Sankyo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Daiichi Sankyo and related companies with MarketBeat.com's FREE daily email newsletter.